UG

Ulrich Goepfert

Hoffmann-La Roche: 24 patents #125 of 3,238Top 4%
Overall (All Time): #158,231 of 4,157,543Top 4%
25
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12358997 Bispecific anti-human A-beta/anti-human transferrin receptor antibodies Harald Duerr, Sebastian Fenn, Sabine Imhof-Jung, Christian Klein, Laurent Lariviere +4 more 2025-07-15
12312606 Nucleic acid constructs for VA RNA transcription Simon Auslaender 2025-05-27
12297263 Humanized anti-Tau(PS422) antibodies and methods of use Stefan Dengl, Thomas Emrich, Guy Georges, Fiona Grueninger, Adrian Hugenmatter +9 more 2025-05-13
12252533 Anti-transferrin receptor antibodies with tailored affinity Stefan Dengl, Guy Georges, Jens Niewoehner, Tilman Schlothauer 2025-03-18
12030952 Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use Harald Duerr, Sebastian Fenn, Sabine Imhof-Jung, Christian Klein, Laurent Lariviere +4 more 2024-07-09
11787868 Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use Harald Duerr, Sebastian Fenn, Sabine Imhof-Jung, Christian Klein, Laurent Lariviere +4 more 2023-10-17
11603411 Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use Harald Duerr, Sebastian Fenn, Sabine Imhof-Jung, Christian Klein, Laurent Lariviere +4 more 2023-03-14
11584793 Anti-transferrin receptor antibodies with tailored affinity Stefan Dengl, Guy Georges, Jens Niewoehner, Tilman Schlothauer 2023-02-21
11572404 Humanized anti-Tau(pS422) antibodies and methods of use Stefan Dengl, Thomas Emrich, Guy Georges, Fiona Grueninger, Adrian Hugenmatter +9 more 2023-02-07
11332797 Method for the selection of a long-term producing cell using histone acylation as markers Peter Becker, Benjamin Moritz 2022-05-17
10941205 Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use Harald Duerr, Sebastian Fenn, Sabine Imhof-Jung, Christian Klein, Laurent Lariviere +4 more 2021-03-09
10822402 Humanized anti-tau(pS422) antibodies and methods of use Stefan Dengl, Thomas Emrich, Guy Georges, Fiona Grueninger, Adrian Hugenmatter +9 more 2020-11-03
10465000 Humanized anti-Tau(pS422) antibodies and methods of use Fiona Grueninger, Guy Georges, Olaf Mundigl, Michael Schraeml, Bernd Bohrmann +2 more 2019-11-05
10329595 CMV promoter and method for production of polypeptides Benjamin Moritz 2019-06-25
10323089 Anti-transferrin receptor antibodies with tailored affinity Stefan Dengl, Guy Georges, Jens Niewoehner, Tilman Schlothauer 2019-06-18
10251952 Humanized anti-tau(pS422) antibody brain shuttles and use thereof Martin Bader 2019-04-09
10151002 Method for the selection of a long-term producing cell Andrea Osterlehner, Silke Lueckel 2018-12-11
9862763 Humanized anti-tau(pS422) antibodies and methods of use Stefan Dengl, Thomas Emrich, Guy Georges, Fiona Grueninger, Adrian Hugenmatter +9 more 2018-01-09
9562091 Humanized anti-Tau(pS422) antibodies and methods of use Fiona Grueninger, Guy Georges, Olaf Mundigl, Michael Schraeml, Bernd Bohrmann +2 more 2017-02-07
9428766 Protein expression from multiple nucleic acids Hendrik Knoetgen, Erhard Kopetzki, Anne Stern 2016-08-30
9290567 Use of an anti-Tau pS422 antibody for the treatment of brain diseases Bernd Bohrmann, Fiona Grueninger, Walter Huber, Hans-Willi Krell, Valeria Lifke +4 more 2016-03-22
8771988 Protein expression from multiple nucleic acids Hendrik Knoetgen, Erhard Kopetzki, Anne Stern 2014-07-08
8609097 Use of an anti-Tau pS422 antibody for the treatment of brain diseases Bernd Bohrmann, Fiona Grueninger, Walter Huber, Hans-Willi Krell, Valeria Lifke +4 more 2013-12-17
8314225 Heavy chain mutant leading to improved immunoglobulin production Silke Hansen, Hendrik Knoetgen, Erhard Kopetzki, Oliver Ploettner 2012-11-20
7892790 Protein expression in rodent cells Erhard Kopetzki 2011-02-22